Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
Breast Cancer (Tokyo, Japan)|August 20, 2002
Systematic overview of quality of life studies for breast cancerKojiro Shimozuma, Takahiro Okamoto, Noriyuki Katsumata, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 27, 2019
Health utility and health-related quality of life of Japanese prostate cancer patients according to progression status measured using EQ-5D-5L and FACT-PHideki Murasawa, Takayuki Sugiyama, Yuki Matsuoka, et al.Breast Cancer (Tokyo, Japan)|September 5, 2003
Measuring quality of life in patients with breast cancer: a systematic review of reliable and valid instruments available in JapanTakahiro Okamoto, Kojiro Shimozuma, Noriyuki Katsumata, et al.Clinical Drug Investigation|March 2, 2022
Cost-Effectiveness of Trastuzumab With or Without Chemotherapy as Adjuvant Therapy in HER2-Positive Elderly Breast Cancer Patients: A Randomized, Open-Label Clinical Trial, the RESPECT TrialYuki Takumoto, Takeru Shiroiwa, Kojiro Shimozuma, et al.Breast Cancer (Tokyo, Japan)|May 16, 2016
Development of a Japanese version of the BREAST-Q and the traditional psychometric test of the mastectomy module for the assessment of HRQOL and patient satisfaction following breast surgeryMiho Saiga, Naruto Taira, Yoshihiro Kimata, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 16, 2012
Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trialKojiro Shimozuma, Yasuo Ohashi, Ayano Takeuchi, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 31, 2009
Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02Kojiro Shimozuma, Yasuo Ohashi, Ayano Takeuchi, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 5, 2019
Factors contributing to the ceiling effect of the EQ-5D-5L: an analysis of patients with prostate cancer judged "no-problems"Hideki Murasawa, Takayuki Sugiyama, Yuki Matsuoka, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 TrialToru Watanabe, Muneaki Sano, Shigemitsu Takashima, et al.Current Medical Research and Opinion|December 12, 2017
Effect of ruxolitinib therapy on the quality-of-life of Japanese patients with myelofibrosisKenji Oritani, Kohshi Ohishi, Shinichiro Okamoto, et al.Pageof 9